New program aims to commercialize Cornell technology

To provide a corporate leg up to technology opportunities and startup companies emerging from research here, the new Cornell Technology Acceleration and Maturation program is designed to propel promising ideas toward commercial viability.

Promising target found for better brain cancer drugs

Cornell researchers have discovered a key component to aggressive brain tumors grow that could lead to better cancer drugs. Their study is published in the June issue of Cell Reports.

Meet North America's only 'snail wrangler'

Marla Coppolino, a staff member of the Cornell Center for Technology Enterprise and Commercialization, also is a snail wrangler, biological illustrator, Nigerian dwarf goat breeder, snail educator and entrepreneur, and a researcher.

Nobel laureate talks life expectancy, antibiotics

Nobel laureate Ada Yonath delivered the 21st Efraim Racker Lecture in Biology and Medicine Nov. 14 on campus.

Mutated white pine rust threatens Northeast trees

A white pine-decimating fungus has mutated, allowing it to infect immune and resistant plants, which is alarming researchers, growers, loggers and forest managers.

Bioengineered ears win first place at World Technology Summit

A method for bioengineering living human ears garnered a first-place award at the World Technology Summit in New York City, Nov. 15.

Before cells, biochemicals may have combined in clay

Tiny spaces in a gel of clay mixed with seawater may have protected and enhanced the evolution of early biomolecules.

Johnson center to lead marine ecosystem group

The Samuel Curtis Johnson Graduate School of Management’s Center for Sustainable Global Enterprise will lead a $2.3 million effort to improve economic links to marine ecosystems.

Cornell partners in structural biology X-ray center

A $25 million National Science Foundation award will fund a Science and Technology Center aimed at transforming the field of structural biology, including drug development, using X-ray lasers.